Zhejiang Xinguang Pharmaceutical Co., Ltd.

SZSE:300519.SZ

15.16 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011
Revenue 267.66270.4351.489320.876283.08291.262276.257310.865315.314311.478292.109267.938249.855229.617
Cost of Revenue 177.117158.795169.232142.133126.533132.079124.48123.722109.536106.457106.994119.774134.57139.9
Gross Profit 90.543111.605182.257178.743156.547159.183151.777187.143205.777205.021185.115148.164115.28589.717
Gross Profit Ratio 0.3380.4130.5190.5570.5530.5470.5490.6020.6530.6580.6340.5530.4610.391
Reseach & Development Expenses 12.62415.13415.54913.5212.0115.89717.77417.69415.10914.10911.31112.84900
General & Administrative Expenses 3.1842.9972.7183.4552.8454.4123.343.9984.0054.2875.3215.82825.26319.415
Selling & Marketing Expenses 18.39419.53133.73932.06132.47730.46828.69932.25336.18733.48731.75332.47524.96225.019
SG&A 21.57822.31836.45635.51635.32234.87932.03936.25140.19237.77437.07438.30350.22544.434
Other Expenses -1.0040.019-1.001-0.6262.303-0.359-0.1850.0146.5440.4981.0342.1276.3780.359
Operating Expenses 33.19837.47169.1026863.04765.69664.88770.8575.67670.25666.53565.66953.1446.626
Operating Income 57.34674.133126.605132.583112.494108.632101.043122.512132.014137.604122.08382.33260.02856.117
Operating Income Ratio 0.2140.2740.360.4130.3970.3730.3660.3940.4190.4420.4180.3070.240.244
Total Other Income Expenses Net -0.34-0.97314.7823.23123.10516.18114.7230.0146.5260.3980.872.1185.7680.359
Income Before Tax 57.00673.16125.604131.957114.797108.273100.857122.526138.539138.003122.95384.4565.79656.476
Income Before Tax Ratio 0.2130.2710.3570.4110.4060.3720.3650.3940.4390.4430.4210.3150.2630.246
Income Tax Expense 6.6168.80416.78317.67715.82114.37212.86216.36719.5819.21917.30111.9818.958.35
Net Income 50.3964.356108.821114.2898.97693.90187.996106.159118.959118.784105.65272.46956.83846.854
Net Income Ratio 0.1880.2380.310.3560.350.3220.3190.3410.3770.3810.3620.270.2270.204
EPS 0.320.40.680.710.620.590.550.660.890.990.880.610.481.56
EPS Diluted 0.320.40.680.710.620.590.550.660.890.990.880.610.481.56
EBITDA 49.3163.708127.84128.207106.308103.68794.754128.567144.512144.054128.98487.60762.61740.551
EBITDA Ratio 0.1840.2360.3640.40.3760.3560.3430.4140.4580.4620.4420.3270.2510.177